ODT
Odonate Therapeutics, Inc. Common Stock
Delisted
ODT was delisted on the 14th of January, 2022.
55 hedge funds and large institutions have $361M invested in Odonate Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 22 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25% less capital invested
Capital invested by funds: $480M → $361M (-$119M)
Holders
55
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$3.53M | |
| 2 | +$2.14M | |
| 3 | +$2.01M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.67M |
| 5 |
Morgan Stanley
New York
|
+$1.1M |
Top Sellers
| 1 | -$5.23M | |
| 2 | -$2.09M | |
| 3 | -$1.94M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$1.43M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.39M |